Summary

The global neurostimulation devices market is set to witness robust expansion over the next decade, according to a new report by Fairfield Market Research. The market is forecast to grow from US$ 7.82 billion in 2025 to US$ 17.4 billion by 2032, registering a notable CAGR of 12.09%. The rising burden of neurological diseases and growing demand for non-invasive pain therapies are key factors shaping the trajectory of this market.

Market Insights

Neurostimulation devices play a critical role in managing chronic neurological and pain-related conditions. These devices deliver targeted electrical impulses to modulate neural activity and are increasingly adopted as alternatives to conventional drug-based therapies. The market has evolved significantly with innovations in implantable technologies and wearable solutions, expanding applications in both hospital and homecare settings.

Among product categories, spinal cord stimulators (SCS) continue to dominate due to their high efficacy in treating chronic pain conditions such as failed back surgery syndrome and complex regional pain syndrome. Non-invasive alternatives like transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS) are also gaining attention for their ease of use and patient compliance.

Market Drivers

The global increase in neurological disorders, including Parkinson’s disease, epilepsy, and chronic migraine, is a major contributor to market growth. Parkinson’s disease alone affects over 1% of people above 60 years and is expected to grow with aging populations, particularly in developed regions.

Another significant growth driver is the rising prevalence of chronic pain, which impacts around 20% to 30% of adults globally. Pain management has emerged as the leading application for neurostimulation, supported by a shift in medical preference toward drug-free treatment modalities that offer long-term relief without the side effects associated with opioids.

In addition, favorable reimbursement frameworks in markets like North America and Europe have facilitated access to neurostimulation therapies. Medicare coverage for spinal cord stimulation and similar procedures, alongside expanding private insurance participation, is creating a strong foundation for market adoption.

Business Opportunity

The emergence of wearable neurostimulation devices represents a major business opportunity. These compact, drug-free solutions provide real-time pain relief and are designed for use outside clinical settings, allowing patients to manage chronic conditions independently.

Products like Quell®, a wearable for nerve stimulation, and CEFALY, which targets migraine relief, highlight the growing trend toward personalized, home-based neurostimulation therapies. Their affordability, ease of use, and non-invasive nature make them appealing to both healthcare providers and consumers.

Incorporation of digital health technologies into neurostimulation devices is another promising area. Advanced models now offer features such as remote programming, AI-enabled feedback loops, and app-based tracking, enhancing treatment precision and overall patient experience.

Regional Outlook

North America is poised to lead the global neurostimulation devices market due to its mature healthcare ecosystem, high disease awareness, and proactive adoption of advanced treatments. The region sees strong uptake of both implantable and wearable devices for conditions like chronic pain and Parkinson’s disease.

Europe follows closely, benefiting from an aging population and supportive healthcare policies. The region’s established medtech infrastructure also facilitates early product approvals and clinical integration.

Meanwhile, Asia Pacific presents untapped potential with rising healthcare investments, urbanization, and growing cases of lifestyle-related neurological disorders. However, limited insurance coverage and high costs remain key hurdles in many emerging markets.

Competitive Analysis

The neurostimulation devices industry features a blend of established medtech giants and innovative newcomers. Companies are pursuing strategies such as acquisitions, product launches, and technology integration to strengthen their market positions.

• Medtronic leads with its Percept™ Deep Brain Stimulation system, known for advanced sensing and rechargeability.

• Boston Scientific has expanded its neuromodulation portfolio with the acquisition of Axonics, specializing in sacral neuromodulation.

• Abbott, NeuroSigma, and NeuroPace are among other prominent players introducing new applications and targeting niche indications like depression and pediatric ADHD.

Recent Developments

In January 2024, Medtronic secured FDA approval for its Percept™ RC system, enhancing its neuromodulation portfolio with a rechargeable platform.

NeuroSigma received FDA clearance for its second-generation Monarch eTNS device, aimed at treating pediatric ADHD without pharmaceuticals.

Boston Scientific entered a US$ 3.4 billion acquisition deal with Axonics to boost its presence in the neuromodulation market focused on urology and bowel dysfunction.

Market Restraints

Despite strong growth prospects, the market faces challenges that could affect adoption. High device costs remain a major barrier, especially for invasive neurostimulation systems that require surgical implantation and long-term maintenance.

Healthcare providers must undergo specialized training, and patients may incur out-of-pocket expenses due to gaps in insurance coverage. This issue is particularly critical in emerging economies where healthcare infrastructure and reimbursement systems are still developing.

Another barrier is limited awareness. In many low-income countries, both patients and providers may lack knowledge about neurostimulation therapies, reducing the likelihood of adoption. Bridging this awareness gap through educational programs and marketing will be essential for expanding global reach.

Future Outlook

Looking ahead, the neurostimulation devices market is set to benefit from the convergence of digital health, minimally invasive procedures, and personalized therapy models. Advanced closed-loop systems, AI-based monitoring, and integration with mobile apps are expected to transform the treatment Analysis.

As the global burden of neurological and chronic pain disorders rises, healthcare systems will increasingly look for effective alternatives to opioids and invasive surgeries. Neurostimulation devices, with their growing versatility and expanding applications, are well-positioned to meet these evolving needs.

Continued investment in R&D, coupled with regulatory support and strategic partnerships, will be crucial in overcoming barriers and unlocking new market segments across geographies.

Market Segmentation

By Product Type

• Spinal Cord Stimulators (SCS)

• Deep Brain Stimulators (DBS)

• Vagus Nerve Stimulators (VNS)

• Sacral Nerve Stimulators

• Transcranial Magnetic Stimulation (TMS) Devices

• Transcutaneous Electrical Nerve Stimulation (TENS) Devices

By Application

• Pain Management

• Epilepsy

• Depression

• Parkinson’s Disease

• Others

By End User

• Hospitals

• Clinics

• Homecare Settings

• Research Institutes

By Region

• North America

• Europe

• Latin America

• Asia Pacific

• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Neurostimulation Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurostimulation Devices Market Outlook, 2019-2032
3.1. Global Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Implantable device
3.1.1.2. External devices
3.2. Global Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Spinal Cord Stimulation
3.2.1.2. Deep Brain Stimulation
3.2.1.3. Sacral Nerve Stimulation
3.2.1.4. Vagus Nerve Stimulation
3.2.1.5. Cochlear Implants
3.2.1.6. Gastric Electric Stimulation
3.3. Global Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Transcutaneous Electrical Nerve Stimulation
3.3.1.2. Transcranial Magnetic Stimulation
3.4. Global Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Pain Management
3.4.1.2. Parkinson’s Disease
3.4.1.3. Urinary and Faecal Incontinence
3.4.1.4. Epilepsy
3.4.1.5. Hearing loss
3.4.1.6. Gastroparesis
3.4.1.7. Depression
3.5. Global Neurostimulation Devices Market Outlook, by Region, Value (US$ Mn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Neurostimulation Devices Market Outlook, 2019-2032
4.1. North America Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Implantable device
4.1.1.2. External devices
4.2. North America Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Spinal Cord Stimulation
4.2.1.2. Deep Brain Stimulation
4.2.1.3. Sacral Nerve Stimulation
4.2.1.4. Vagus Nerve Stimulation
4.2.1.5. Cochlear Implants
4.2.1.6. Gastric Electric Stimulation
4.3. North America Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Transcutaneous Electrical Nerve Stimulation
4.3.1.2. Transcranial Magnetic Stimulation
4.4. North America Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Pain Management
4.4.1.2. Parkinson’s Disease
4.4.1.3. Urinary and Faecal Incontinence
4.4.1.4. Epilepsy
4.4.1.5. Hearing loss
4.4.1.6. Gastroparesis
4.4.1.7. Depression
4.5. North America Neurostimulation Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
4.5.1.2. U.S. Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
4.5.1.3. U.S. Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
4.5.1.4. U.S. Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
4.5.1.5. Canada Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
4.5.1.6. Canada Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
4.5.1.7. Canada Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
4.5.1.8. Canada Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurostimulation Devices Market Outlook, 2019-2032
5.1. Europe Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Implantable device
5.1.1.2. External devices
5.2. Europe Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Spinal Cord Stimulation
5.2.1.2. Deep Brain Stimulation
5.2.1.3. Sacral Nerve Stimulation
5.2.1.4. Vagus Nerve Stimulation
5.2.1.5. Cochlear Implants
5.2.1.6. Gastric Electric Stimulation
5.3. Europe Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Transcutaneous Electrical Nerve Stimulation
5.3.1.2. Transcranial Magnetic Stimulation
5.4. Europe Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Pain Management
5.4.1.2. Parkinson’s Disease
5.4.1.3. Urinary and Faecal Incontinence
5.4.1.4. Epilepsy
5.4.1.5. Hearing loss
5.4.1.6. Gastroparesis
5.4.1.7. Depression
5.5. Europe Neurostimulation Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.2. Germany Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.3. Germany Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.4. Germany Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.5. U.K. Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.6. U.K. Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.7. U.K. Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.8. U.K. Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.9. France Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.10. France Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.11. France Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.12. France Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.13. Italy Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.14. Italy Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.15. Italy Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.16. Italy Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.17. Turkey Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.18. Turkey Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.19. Turkey Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.20. Turkey Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.21. Russia Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.22. Russia Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.23. Russia Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.24. Russia Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.1.25. Rest of Europe Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
5.5.1.26. Rest of Europe Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
5.5.1.27. Rest of Europe Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
5.5.1.28. Rest of Europe Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurostimulation Devices Market Outlook, 2019-2032
6.1. Asia Pacific Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Implantable device
6.1.1.2. External devices
6.2. Asia Pacific Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Spinal Cord Stimulation
6.2.1.2. Deep Brain Stimulation
6.2.1.3. Sacral Nerve Stimulation
6.2.1.4. Vagus Nerve Stimulation
6.2.1.5. Cochlear Implants
6.2.1.6. Gastric Electric Stimulation
6.3. Asia Pacific Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Transcutaneous Electrical Nerve Stimulation
6.3.1.2. Transcranial Magnetic Stimulation
6.4. Asia Pacific Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Pain Management
6.4.1.2. Parkinson’s Disease
6.4.1.3. Urinary and Faecal Incontinence
6.4.1.4. Epilepsy
6.4.1.5. Hearing loss
6.4.1.6. Gastroparesis
6.4.1.7. Depression
6.5. Asia Pacific Neurostimulation Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.2. China Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.3. China Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.4. China Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.1.5. Japan Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.6. Japan Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.7. Japan Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.8. Japan Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.1.9. South Korea Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.10. South Korea Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.11. South Korea Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.12. South Korea Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.1.13. India Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.14. India Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.15. India Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.16. India Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.1.17. Southeast Asia Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.18. Southeast Asia Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.19. Southeast Asia Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.20. Southeast Asia Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.1.21. Rest of Asia Pacific Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
6.5.1.22. Rest of Asia Pacific Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
6.5.1.23. Rest of Asia Pacific Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
6.5.1.24. Rest of Asia Pacific Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurostimulation Devices Market Outlook, 2019-2032
7.1. Latin America Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Implantable device
7.1.1.2. External devices
7.2. Latin America Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
7.2.1.1. Spinal Cord Stimulation
7.2.1.2. Deep Brain Stimulation
7.2.1.3. Sacral Nerve Stimulation
7.2.1.4. Vagus Nerve Stimulation
7.2.1.5. Cochlear Implants
7.2.1.6. Gastric Electric Stimulation
7.3. Latin America Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Transcutaneous Electrical Nerve Stimulation
7.3.1.2. Transcranial Magnetic Stimulation
7.4. Latin America Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Pain Management
7.4.1.2. Parkinson’s Disease
7.4.1.3. Urinary and Faecal Incontinence
7.4.1.4. Epilepsy
7.4.1.5. Hearing loss
7.4.1.6. Gastroparesis
7.4.1.7. Depression
7.5. Latin America Neurostimulation Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
7.5.1.2. Brazil Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
7.5.1.3. Brazil Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
7.5.1.4. Brazil Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
7.5.1.5. Mexico Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
7.5.1.6. Mexico Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
7.5.1.7. Mexico Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
7.5.1.8. Mexico Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
7.5.1.9. Argentina Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
7.5.1.10. Argentina Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
7.5.1.11. Argentina Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
7.5.1.12. Argentina Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
7.5.1.13. Rest of Latin America Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
7.5.1.14. Rest of Latin America Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
7.5.1.15. Rest of Latin America Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
7.5.1.16. Rest of Latin America Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurostimulation Devices Market Outlook, 2019-2032
8.1. Middle East & Africa Neurostimulation Devices Market Outlook, by Device Type, Value (US$ Mn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Implantable device
8.1.1.2. External devices
8.2. Middle East & Africa Neurostimulation Devices Market Outlook, by Implantable Devices, Value (US$ Mn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Spinal Cord Stimulation
8.2.1.2. Deep Brain Stimulation
8.2.1.3. Sacral Nerve Stimulation
8.2.1.4. Vagus Nerve Stimulation
8.2.1.5. Cochlear Implants
8.2.1.6. Gastric Electric Stimulation
8.3. Middle East & Africa Neurostimulation Devices Market Outlook, by External Devices, Value (US$ Mn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Transcutaneous Electrical Nerve Stimulation
8.3.1.2. Transcranial Magnetic Stimulation
8.4. Middle East & Africa Neurostimulation Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Pain Management
8.4.1.2. Parkinson’s Disease
8.4.1.3. Urinary and Faecal Incontinence
8.4.1.4. Epilepsy
8.4.1.5. Hearing loss
8.4.1.6. Gastroparesis
8.4.1.7. Depression
8.5. Middle East & Africa Neurostimulation Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
8.5.1.2. GCC Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
8.5.1.3. GCC Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
8.5.1.4. GCC Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
8.5.1.5. South Africa Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
8.5.1.6. South Africa Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
8.5.1.7. South Africa Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
8.5.1.8. South Africa Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
8.5.1.9. Egypt Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
8.5.1.10. Egypt Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
8.5.1.11. Egypt Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
8.5.1.12. Egypt Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
8.5.1.13. Nigeria Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
8.5.1.14. Nigeria Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
8.5.1.15. Nigeria Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
8.5.1.16. Nigeria Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Neurostimulation Devices Market by Device Type, Value (US$ Mn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Neurostimulation Devices Market Implantable Devices, Value (US$ Mn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Neurostimulation Devices Market External Devices, Value (US$ Mn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Neurostimulation Devices Market Application, Value (US$ Mn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. External Devices vs Implantable Devices Heatmap
9.2. Manufacturer vs Implantable Devices Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Medtronic plc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. St. Jude Medical, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Boston Scientific Corporation
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Cyberonics, Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Cochlear, Ltd.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. NeuroPace, Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. NeuroSigma, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. NDI Medical, LLC
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. MED-EL
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations